0000899243-23-012077.txt : 20230503 0000899243-23-012077.hdr.sgml : 20230503 20230503160522 ACCESSION NUMBER: 0000899243-23-012077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Richard A CENTRAL INDEX KEY: 0001490283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40657 FILM NUMBER: 23883638 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Therapeutics, Inc. CENTRAL INDEX KEY: 0001850838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 949-4360 MAIL ADDRESS: STREET 1: 20 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-01 0 0001850838 Omega Therapeutics, Inc. OMGA 0001490283 Young Richard A C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 1 0 0 0 1 Common Stock 2023-05-01 4 S 0 5000 8.00 D 744118 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022. /s/ Barbara Chan as Attorney-in-Fact for Richard A. Young, Ph.D. 2023-05-03